Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals

NCT04681430 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Corona Virus Infection
SARS-CoV-2 Infection
SARS-CoV-2 PCR Test Positive
SARS-CoV-2 Acute Respiratory Disease

Interventions

BIOLOGICAL: Convalescent plasma
DRUG: Camostat Mesilate
DRUG: Placebo for Camostat Mesilate
OTHER: Standard of Care (SoC)

Sponsor

Heinrich-Heine University, Duesseldorf

Collaborators

[object Object]